This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Venaxis Inc
APPY : NASDAQ : Health Care
$1.80 | %
Today's Range: 1.69 - 1.80
Avg. Daily Volume: 193,400
12/19/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
APPY VENAXIS INC 1.71 52.99 n/m 0.18 34.55
CGIX CANCER GENETICS INC 7.19 69.92 n/m 8.02 37.52
VCEL VERICEL CORP 2.88 68.50 n/m 14.10 46893.33
STEM STEMCELLS INC 0.99 68.04 n/m 1.16 5.53
CPXX CELATOR PHARMACEUTICALS INC 1.80 60.63 n/m 1.04 672.59
LPTN LPATH INC 2.91 56.10 n/m 6.47 -5.77
CVM CEL-SCI CORP 0.58 52.85 n/m 0.21 -15.88
IBIO IBIO INC 0.70 50.33 n/m 1.06 61.46
HEB HEMISPHERX BIOPHARMA INC 0.25 50.01 n/m 0.19 15.56
OGXI ONCOGENEX PHARMACEUTICALS 2.28 48.52 n/m 30.07 -3.20
CYTX CYTORI THERAPEUTICS INC 0.51 47.15 n/m 7.29 -54.62
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

APPY Ind Avg S&P 500
n/m 71.67 19.99
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs